Genetic insights in the pathogenesis of T-cell acute lymphoblastic leukemia.
暂无分享,去创建一个
[1] Peter Marynen,et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). , 2005, Blood.
[2] Sandra A. Moore,et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. , 2005, Cancer cell.
[3] Peter M Fischer,et al. Recent progress in the discovery and development of cyclin-dependent kinase inhibitors , 2005, Expert opinion on investigational drugs.
[4] Hiroshi Hirai,et al. Recent advances in the development of selective small molecule inhibitors for cyclin-dependent kinases. , 2005, Current topics in medicinal chemistry.
[5] Tannishtha Reya,et al. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance , 2005, Nature Immunology.
[6] P. Marynen,et al. A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias , 2005, Leukemia.
[7] P. Marynen,et al. e6-a2 BCR-ABL1 fusion in T-cell acute lymphoblastic leukemia , 2005, Leukemia.
[8] J. Licht,et al. Therapeutic intervention in leukemias that express the activated fms-like tyrosine kinase 3 (FLT3): opportunities and challenges , 2005, Current opinion in hematology.
[9] J. Gotlib. Farnesyltransferase inhibitor therapy in acute myelogenous leukemia. , 2005, Current hematology reports.
[10] E. Macintyre,et al. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. , 2004, Blood.
[11] Ping Chen,et al. Discovery of N-(2-chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. , 2004, Journal of medicinal chemistry.
[12] U. Kees,et al. A microarray model system identifies potential new target genes of the proto‐oncogene HOX11 , 2004, Genes, chromosomes & cancer.
[13] A. Ferrando,et al. Various types of rearrangements target TLX3 locus in T‐cell acute lymphoblastic leukemia , 2004, Genes, chromosomes & cancer.
[14] J. Aster,et al. Notch Subunit Heterodimerization and Prevention of Ligand-Independent Proteolytic Activation Depend, Respectively, on a Novel Domain and the LNR Repeats , 2004, Molecular and Cellular Biology.
[15] Arthur Weiss,et al. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation , 2004, Oncogene.
[16] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[17] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[18] D. Gilliland,et al. Blasts from the past: new lessons in stem cell biology from chronic myelogenous leukemia. , 2004, Cancer cell.
[19] L. Platanias,et al. Inhibition of phosphatidylinositol 3'-kinase induces preferentially killing of PTEN-null T leukemias through AKT pathway. , 2004, Biochemical and biophysical research communications.
[20] P. Zipfel,et al. Requirement for Abl Kinases in T Cell Receptor Signaling , 2004, Current Biology.
[21] A. Ferrando,et al. Activating FLT3 mutations in CD117/KIT(+) T-cell acute lymphoblastic leukemias. , 2004, Blood.
[22] J. O'neil,et al. TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB. , 2004, Cancer cell.
[23] Freddy Radtke,et al. Notch regulation of lymphocyte development and function , 2004, Nature Immunology.
[24] A. Ferrando,et al. Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia. , 2004, Blood.
[25] M. Caligiuri,et al. Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia , 2004, The Lancet.
[26] F. Schweisguth,et al. Regulation of Notch Signaling Activity , 2004, Current Biology.
[27] F. Speleman,et al. Clinical significance of HOX11L2 expression linked to t(5;14)(q35;q32), of HOX11 expression, and of SIL-TAL fusion in childhood T-cell malignancies: results of EORTC studies 58881 and 58951. , 2004, Blood.
[28] J. V. van Dongen,et al. Two dual-color split signal fluorescence in situ hybridization assays to detect t(5;14) involving HOX11L2 or CSX in T-cell acute lymphoblastic leukemia. , 2004, Haematologica.
[29] I. Weissman,et al. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. , 2003, Genes & development.
[30] A. Ferrando,et al. Gene expression profiling in T-cell acute lymphoblastic leukemia. , 2003, Seminars in hematology.
[31] F. Speleman,et al. t(5;14)/HOX11L2-positive T-cell acute lymphoblastic leukemia. A collaborative study of the Groupe Français de Cytogénétique Hématologique (GFCH) , 2003, Leukemia.
[32] H. Drexler,et al. The cardiac homeobox gene NKX2-5 is deregulated by juxtaposition with BCL11B in pediatric T-ALL cell lines via a novel t(5;14)(q35.1;q32.2). , 2003, Cancer research.
[33] E. Macintyre,et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRγδ lineage , 2003 .
[34] S. Armstrong,et al. Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation. , 2003, Blood.
[35] F. Weerkamp,et al. Homeobox gene expression profile in human hematopoietic multipotent stem cells and T-cell progenitors: implications for human T-cell development , 2003, Leukemia.
[36] H. Cavé,et al. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono‐ and bi‐allelic 9p21 deletions in childhood acute lymphoblastic leukemia , 2003, Genes, chromosomes & cancer.
[37] M. Seminario,et al. Lipid phosphatases in the regulation of T cell activation: living up to their PTEN‐tial , 2003, Immunological reviews.
[38] D. Wechsler,et al. A novel chromosomal inversion at 11q23 in infant acute myeloid leukemia fuses MLL to CALM, a gene that encodes a clathrin assembly protein , 2003, Genes, chromosomes & cancer.
[39] E. Macintyre,et al. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. , 2003, Blood.
[40] D. Gilliland,et al. Genetics of myeloid leukemias. , 2003, Annual review of genomics and human genetics.
[41] B. Owens,et al. HOX and Non‐HOX Homeobox Genes in Leukemic Hematopoiesis , 2002, Stem cells.
[42] J. Griffin,et al. The roles of FLT3 in hematopoiesis and leukemia. , 2002, Blood.
[43] J. Zucman‐Rossi,et al. HOX11L2 expression defines a clinical subtype of pediatric T-ALL associated with poor prognosis. , 2002, Blood.
[44] F. McCormick,et al. The RB and p53 pathways in cancer. , 2002, Cancer cell.
[45] Alex Matter,et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.
[46] H. Macdonald,et al. Inactivation of Notch1 impairs VDJbeta rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. , 2002, Immunity.
[47] B. Verhasselt,et al. HOX-A10 regulates hematopoietic lineage commitment: evidence for a monocyte-specific transcription factor. , 2002, Blood.
[48] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[49] B. Schraven,et al. Adapters in lymphocyte signaling. , 2002, The Journal of clinical investigation.
[50] R. Heilig,et al. A new recurrent and specific cryptic translocation, t(5;14)(q35;q32), is associated with expression of the Hox11L2 gene in T acute lymphoblastic leukemia , 2001, Leukemia.
[51] Charles J. Sherr,et al. The INK4a/ARF network in tumour suppression , 2001, Nature Reviews Molecular Cell Biology.
[52] S. Ward,et al. Phosphoinositide 3-kinases in T lymphocyte activation. , 2001, Current opinion in immunology.
[53] S. Latour,et al. Proximal protein tyrosine kinases in immunoreceptor signaling. , 2001, Current opinion in immunology.
[54] C. Buske,et al. Overexpression of HOXA10 perturbs human lymphomyelopoiesis in vitro and in vivo. , 2001, Blood.
[55] P. Marynen,et al. Molecular cytogenetic and clinical findings in ETV6/ABL1‐positive leukemia , 2001, Genes, chromosomes & cancer.
[56] D. Gilliland. Hematologic malignancies. , 2001, Current opinion in hematology.
[57] U. Kees,et al. Promoter demethylation accompanies reactivation of the HOX11 proto‐oncogene in leukemia , 2000, Genes, chromosomes & cancer.
[58] J. Shuster,et al. New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 cases. , 2000, Blood.
[59] O. Bernard,et al. TEL-JAK2 transgenic mice develop T-cell leukemia. , 2000, Blood.
[60] C. Buske,et al. Homeobox genes in leukemogenesis. , 2000, International journal of hematology.
[61] M. Diccianni,et al. Ras activation in normal white blood cells and childhood acute lymphoblastic leukemia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[62] M. Diccianni,et al. Universal inactivation of both p16 and p15 but not downstream components is an essential event in the pathogenesis of T-cell acute lymphoblastic leukemia. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[63] J. Sklar,et al. Calcium Depletion Dissociates and Activates Heterodimeric Notch Receptors , 2000, Molecular and Cellular Biology.
[64] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[65] C. Meijer,et al. The role of Homeobox genes in normal hematopoiesis and hematological malignancies , 1999, Leukemia.
[66] H. Macdonald,et al. Deficient T cell fate specification in mice with an induced inactivation of Notch1. , 1999, Immunity.
[67] Channing J Der,et al. Increasing complexity of Ras signaling , 1998, Oncogene.
[68] L. Chin,et al. The INK4a/ARF tumor suppressor: one gene--two products--two pathways. , 1998, Trends in biochemical sciences.
[69] H. Kaneko,et al. Mutational analysis of the N-ras gene in acute lymphoblastic leukemia: a study of 125 Japanese pediatric cases. , 1998, International journal of hematology.
[70] N. Heerema,et al. Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[71] R Berger,et al. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia. , 1997, Science.
[72] K. Gross,et al. An scl gene product lacking the transactivation domain induces bony abnormalities and cooperates with LMO1 to generate T‐cell malignancies in transgenic mice , 1997, The EMBO journal.
[73] N. Zhang,et al. Transforming function of the HOX11/TCL3 homeobox gene. , 1997, Cancer research.
[74] U. Thorsteinsdóttir,et al. Overexpression of HOXA10 in murine hematopoietic cells perturbs both myeloid and lymphoid differentiation and leads to acute myeloid leukemia , 1997, Molecular and cellular biology.
[75] J. Rowley,et al. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[76] M. Cleary,et al. Helix-loop-helix proteins LYL1 and E2a form heterodimeric complexes with distinctive DNA-binding properties in hematolymphoid cells , 1996, Molecular and cellular biology.
[77] S. Smith,et al. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells. , 1996, Leukemia.
[78] T. Rabbitts,et al. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. , 1996, The EMBO journal.
[79] A. Levitzki,et al. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor , 1996, Nature.
[80] J. Herman,et al. Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.
[81] U. Kees,et al. HOX11 expression in pediatric acute lymphoblastic leukemia is associated with T-cell phenotype. , 1995, Oncogene.
[82] A. Hagemeijer,et al. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene. , 1995, Blood.
[83] M. Sofroniew,et al. The Hox11 gene is essential for cell survival during spleen development. , 1995, Development.
[84] M. Amylon,et al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. , 1995, Blood.
[85] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[86] R. Hanada,et al. Mutations of the p53 and ras genes in childhood t(1;19)-acute lymphoblastic leukemia. , 1995, Blood.
[87] F. Sigaux,et al. Candidate tumor-suppressor genes MTS1 (p16INK4A) and MTS2 (p15INK4B) display frequent homozygous deletions in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemias. , 1994, Blood.
[88] A. Okamoto,et al. Mutations and altered expression of p16INK4 in human cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[89] I. Mérida,et al. T cell receptor-associated alpha-phosphatidylinositol 3-kinase becomes activated by T cell receptor cross-linking and requires pp56lck. , 1994, The Journal of biological chemistry.
[90] M. Cobb,et al. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity. , 1994, Oncogene.
[91] N. Kohl,et al. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic , 1994, Cell.
[92] S. Korsmeyer,et al. Hox11 controls the genesis of the spleen , 1994, Nature.
[93] B. Sefton,et al. Oncogenic activation of the Lck protein accompanies translocation of the LCK gene in the human HSB2 T-cell leukemia , 1994, Molecular and cellular biology.
[94] R. Kingston,et al. Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteins , 1994, Molecular and cellular biology.
[95] T. Hawley,et al. The HOX11 homeobox-containing gene of human leukemia immortalizes murine hematopoietic precursors. , 1994, Oncogene.
[96] R. Baer. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia. , 1993, Seminars in cancer biology.
[97] C. Largman,et al. Homeobox Genes in Normal Hematopoiesis and Leukemia , 1992 .
[98] R. Espinosa,et al. TAL2, a helix-loop-helix gene activated by the (7;9)(q34;q32) translocation in human T-cell leukemia. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[99] S. Kamel‐Reid,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14) , 1991 .
[100] T. Rabbitts,et al. HOX11, a homeobox-containing T-cell oncogene on human chromosome 10q24. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[101] W. Ludwig,et al. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). , 1991, Oncogene.
[102] M. Lu,et al. The tcl‐3 proto‐oncogene altered by chromosomal translocation in T‐cell leukemia codes for a homeobox protein. , 1991, The EMBO journal.
[103] J. Sklar,et al. Chromosomal translocations joining LCK and TCRB loci in human T cell leukemia , 1991, The Journal of experimental medicine.
[104] J. Sklar,et al. TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms , 1991, Cell.
[105] E. Boncinelli,et al. Coordinate regulation of HOX genes in human hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[106] S. Korsmeyer,et al. Deregulation of a homeobox gene, HOX11, by the t(10;14) in T cell leukemia. , 1991, Science.
[107] H. Hsu,et al. Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins , 1991, Molecular and cellular biology.
[108] M. Perutz,et al. The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[109] J. Visvader,et al. Differential expression of the LYL, SCL and E2A helix-loop-helix genes within the hemopoietic system. , 1991, Oncogene.
[110] S. Raimondi,et al. A novel human homeobox gene lies at the chromosome 10 breakpoint in lymphoid neoplasias with chromosomal translocation t(10;14). , 1991, Blood.
[111] I. Kirsch,et al. Disruption of the human SCL locus by "illegitimate" V-(D)-J recombinase activity. , 1990, Science.
[112] M. Amylon,et al. The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1990, Blood.
[113] F. Mitelman,et al. Bone marrow karyotypes in 94 children with acute leukemia , 1990, European journal of haematology.
[114] F. McCormick,et al. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. , 1990, Blood.
[115] A. Carroll,et al. The tal gene undergoes chromosome translocation in T cell leukemia and potentially encodes a helix‐loop‐helix protein. , 1990, The EMBO journal.
[116] R. Berger,et al. Two distinct mechanisms for the SCL gene activation in the t(1;14) translocation of T‐cell leukemias , 1990, Genes, chromosomes & cancer.
[117] T. Waldmann,et al. The gene SCL is expressed during early hematopoiesis and encodes a differentiation-related DNA-binding motif. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[118] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[119] Y. Jan,et al. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence , 1989, Cell.
[120] R. Berger,et al. Chromosomal rearrangement on chromosome 11q14-q21 in T cell acute lymphoblastic leukemia. , 1989, Leukemia.
[121] M. Cleary,et al. lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif , 1989, Cell.
[122] P. Nowell,et al. Involvement of the TCL5 gene on human chromosome 1 in T-cell leukemia and melanoma. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[123] S. Korsmeyer,et al. The t(11;14)(p15;q11) in a T-cell acute lymphoblastic leukemia cell line activates multiple transcripts, including Ttg-1, a gene encoding a potential zinc finger protein , 1989, Molecular and cellular biology.
[124] F. Behm,et al. Cytogenetics of childhood T-cell leukemia , 1988 .
[125] F. Sigaux,et al. Cytogenetic studies on 519 consecutive de novo acute nonlymphocytic leukemias. , 1987, Cancer genetics and cytogenetics.
[126] S. Sait,et al. Recurrent involvement of 11q13 in acute nonlymphocytic leukemia. , 1987, Cancer genetics and cytogenetics.
[127] A. Hagemeijer,et al. bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia. , 1986, Blood.
[128] A. Palumbo,et al. Gene for alpha-chain of human T-cell receptor: location on chromosome 14 region involved in T-cell neoplasms. , 1985, Science.
[129] A. Look,et al. New chromosomal translocations correlate with specific immunophenotypes of childhood acute lymphoblastic leukemia , 1984, Cell.
[130] J. Stephenson,et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia , 1982, Nature.
[131] A. Okamoto,et al. Mutations and altered expression of p 16 INK 4 in human cancer ( p 53 protein / tumor-suppressor gene / cyclin Di / retinoblastoma protein ) , 2022 .